PACH

Business Context and Reporting Period

Pioneer Acquisition I Corp (PACH) is a Cayman Islands exempted company incorporated on August 28, 2024, operating as a Special Purpose Acquisition Company (SPAC). The company focuses on identifying and acquiring businesses in the healthcare or healthcare-related sectors. This Form 10-K covers the fiscal year ended December 31, 2025. The company consummated its Initial Public Offering (IPO) on June 20, 2025, and has not yet selected a specific business combination target.

Key Financial Metrics

Material Changes vs. Prior Period

• Capital Raise: The company transitioned from a pre-IPO entity to a public company following the June 20, 2025 IPO. Gross proceeds totaled $253,000,000 from the sale of 25,300,000 units (including full exercise of the over-allotment option) and $6,400,000 from the private placement of warrants.
• Trust Account: As of December 31, 2024, the Trust Account balance was $0. As of December 31, 2025, the balance stood at $258,327,825, reflecting the deposit of IPO proceeds and accrued interest.
• Profitability: The company reported a net loss of $(55,148) for the period from inception through December 31, 2024. For the full year ended December 31, 2025, the company reported net income of $4,782,280, driven primarily by unrealized returns on investments held in the Trust Account.
• Share Structure: Class A ordinary shares subject to possible redemption were recorded at $258,327,825 (approx. $10.21 per share) as of December 31, 2025, compared to zero in the prior period.

Guidance, Outlook, and Risks

Outlook and Strategy: The company has 24 months from the IPO closing (until June 20, 2027) to complete an initial business combination. It intends to focus on targets with an enterprise value between $160 million and $2.0 billion in the healthcare sector. Management expects to use funds from the Trust Account, private placement proceeds, and potential additional financing to consummate a transaction.

Management Commentary: Management believes the team's extensive experience in healthcare, private equity, and capital markets provides a competitive advantage in sourcing and executing transactions. The company has not yet identified a target.

Risks and Contingencies:

• Liquidity: While the company has sufficient funds for working capital for at least one year, it relies on the Trust Account for the business combination. If the combination is not completed within the deadline, the company must liquidate.
• Redemption Risk: Public shareholders have the right to redeem their shares for a pro rata portion of the Trust Account. Significant redemptions could reduce the cash available for the transaction.
• Regulatory Environment: The company is subject to the SEC's 2024 SPAC Rules, which impose additional disclosure requirements and may affect the ability to negotiate and complete a business combination.
• Going Concern: The filing notes that the company's ability to continue as a going concern is dependent on completing a business combination. However, management determined that funds are sufficient for operations for at least one year from the issuance date.

Investor Verification Checklist

• Trust Account Balance: Verify the current balance per share in the Trust Account, which was approximately $10.21 as of December 31, 2025, to assess the redemption value.
• Extension Provisions: Review the terms under which the company can extend the 24-month deadline to complete a business combination and the associated shareholder redemption rights.
• Related Party Transactions: Confirm the status of the $10,000 monthly administrative fee paid to the Sponsor and any outstanding loans or convertible notes from the Sponsor or affiliates.
• Deferred Underwriting Fees: Note the $12,045,000 deferred underwriting commission payable only upon the successful completion of a business combination.
• Warrant Terms: Review the exercise price ($11.50) and redemption triggers for the 19,050,000 outstanding warrants (12,650,000 public and 6,400,000 private).